Loading…
UTI - Pharma & Healthcare Fund
Disclosed for 41 months, Jan 2014 to Jun 2017. This scheme is no longer reporting.
Portfolio value
₹321 Cr
down ₹3.4 Cr vs Dec 2015
- Stocks held
- 25
- unchanged
- Top 10 weight
- 70.4%
- of the portfolio in its ten largest
- Cash & debt
- 9.4%
- cash, money market and debt
UTI - Pharma & Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In January 2016 it disclosed 25 stocks worth ₹321 Cr, down ₹3.4 Cr from Dec 2015. Its largest positions were Sun Pharmaceutical Industries Limited (22.9%), Lupin Limited (10.4%), Dr. Reddy's Laboratories Limited (9.3%); the ten largest together made up 70.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 86.7% of its equity. Cash and debt stood at 9.4%. Compared with Dec 2015 the fund entered 1 new stock and exited 1.
Against 230 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
8%
Holds more stocks than 8% of peers
Cash
92%
Holds more cash than 92% of peers
What these mean: concentration · cash
Holdings in January 2016
Download CSVEvery line the fund disclosed, with the change against Dec 2015. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 22.94% | up 2.83 pts | ₹73.6 Cr | up ₹8.4 Cr | Added |
| Lupin Limited | 10.36% | down 0.65 pts | ₹33.3 Cr | down ₹2.5 Cr | Trimmed |
| Cash, TREPS & receivables | 9.38% | down 1.39 pts | ₹30.1 Cr | down ₹4.8 Cr | Trimmed |
| Dr. Reddy's Laboratories Limited | 9.33% | up 0.09 pts | ₹29.9 Cr | down ₹3 L | Held |
| Cipla Limited | 8.07% | down 0.80 pts | ₹25.9 Cr | down ₹2.9 Cr | Trimmed |
| Divi's Laboratories Limited | 4.61% | down 0.01 pts | ₹14.8 Cr | down ₹18 L | Trimmed |
| Aurobindo Pharma Limited | 3.94% | down 0.15 pts | ₹12.6 Cr | down ₹63 L | Trimmed |
| IPCA Laboratories Limited | 3.05% | down 0.30 pts | ₹9.8 Cr | down ₹1.1 Cr | Trimmed |
| Biocon Limited | 2.77% | up 0.92 pts | ₹8.9 Cr | up ₹2.9 Cr | Added |
| Piramal Enterprises Limited | 2.70% | down <0.01 pts | ₹8.7 Cr | down ₹9 L | Trimmed |
| Narayana Hrudayalaya Limited | 2.62% | up 2.62 pts | ₹8.4 Cr | up ₹8.4 Cr | New |
| Alkem Laboratories Limited | 2.35% | down 0.19 pts | ₹7.6 Cr | down ₹70 L | Trimmed |
| Sun Pharma Advanced Research Company Limited | 2.27% | down 0.17 pts | ₹7.3 Cr | down ₹63 L | Trimmed |
| Zydus Lifesciences Limited | 2.04% | down 0.34 pts | ₹6.5 Cr | down ₹1.2 Cr | Trimmed |
| Pfizer Limited | 2.02% | down 0.09 pts | ₹6.5 Cr | down ₹36 L | Trimmed |
| Strides Pharma Science Limited | 2.02% | down 0.19 pts | ₹6.5 Cr | down ₹67 L | Trimmed |
| Sanofi India Limited | 1.55% | down 0.03 pts | ₹5 Cr | down ₹15 L | Trimmed |
| Unichem Laboratories Limited | 1.30% | down 0.14 pts | ₹4.2 Cr | down ₹49 L | Trimmed |
| GlaxoSmithKline Pharmaceuticals Limited | 1.29% | down 0.02 pts | ₹4.1 Cr | down ₹10 L | Trimmed |
| Syngene International Limited | 1.24% | down 0.03 pts | ₹4 Cr | down ₹14 L | Trimmed |
| Indraprastha Medical Corporation Limited | 1.10% | down 0.18 pts | ₹3.5 Cr | down ₹63 L | Trimmed |
| Natco Pharma Limited | 1.00% | down 0.08 pts | ₹3.2 Cr | down ₹31 L | Trimmed |
| DISHMAN PHARMACEUTICALS & CHEMICALS LTD. | 0.62% | down 0.01 pts | ₹2 Cr | down ₹7 L | Trimmed |
| Torrent Pharmaceuticals Limited | 0.62% | down 0.02 pts | ₹2 Cr | down ₹8 L | Trimmed |
| Indoco Remedies Limited | 0.45% | down <0.01 pts | ₹1.4 Cr | down ₹2 L | Trimmed |
| Shilpa Medicare Limited | 0.37% | down 0.08 pts | ₹1.2 Cr | down ₹29 L | Trimmed |
What changed, Dec 2015 to Jan 2016
New New positions (1)
- Narayana Hrudayalaya Limited2.6% · ₹8.4 Cr
Exited Exited (1)
- EQ NARAYANA HRUDAYALAYA LTDwas 1.6% · ₹5.1 Cr
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹8.4 Cr (+2.83% pts)
- Biocon Limitedup ₹2.9 Cr (+0.92% pts)
Trimmed Biggest reductions
- Cipla Limited ₹2.9 Cr (−0.80% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2015, the weight rose most in Healthcare Services (+2.6 pts), and fell most in Pharmaceuticals & Biotechnology (−1.9 pts) and Pharmaceuticals (−0.6 pts).
- Healthcare Services2.9% → 5.5%+2.6 pts
- Pharmaceuticals & Biotechnology88.6% → 86.7%−1.9 pts
- Pharmaceuticals5.4% → 4.8%−0.6 pts
- Finance3.1% → 3.0%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2015 | Jul 2015 | Oct 2015 | Dec 2015 | Jan 2016 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 86.5% | 92.7% | 89.6% | 88.6% | 86.7% |
| Healthcare Services | — | — | 2.4% | 2.9% | 5.5% |
| Pharmaceuticals | 12.5% | 6.3% | 5.2% | 5.4% | 4.8% |
| Finance | 1.0% | 1.0% | 2.7% | 3.1% | 3.0% |
Allocation in Jan 2016change vs Dec 2015
- Pharmaceuticals & Biotechnology (17)86.7%▼ 1.9 pts
- Healthcare Services (3)5.5%▲ 2.6 pts
- Pharmaceuticals (4)4.8%▼ 0.6 pts
- Finance (1)3.0%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2016
9.4%
▼ 1.4 pts vs Dec 2015
- Cash alone
- 9.4%
- cash and net receivables
- A year earlier
- 5.5%
- Jan 2015 · now ▲ 3.9 pts
- Last 12 months
- 5.3% – 12.6%
- lowest to highest · record 12.6% in Nov 2015
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.